Progrezo Pharmaceuticals Private Limited
About Progrezo Pharmaceuticals Private Limited
Data last updated:
Progrezo Pharmaceuticals Private Limited was a private limited company based in Karnal, Haryana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 07 April 2015.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74140HR2015PTC055103. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Anshul Gupta and Anjani Kumar.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Plot No 147 Sector 3 Hsiidc Industrial Estate, Karnal, Haryana, India – 132001.
As per the financials filed for FY 2018, the company reported a revenue of ₹23.99 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹15,832 (net margin 0.7%) and EBITDA of ₹43,990 (EBITDA margin 1.8%).
Company details
Contact details
Progrezo Pharmaceuticals Private Limited's registered office is in Karnal, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 147 Sector 3 Hsiidc Industrial Estate, Karnal, Haryana, India – 132001
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Progrezo Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Progrezo Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Progrezo Pharmaceuticals Private Limited, buy the company report.
Financials of Progrezo Pharmaceuticals Private Limited
FY 2018 filings availableProgrezo Pharmaceuticals Private Limited reported revenue of ₹23.99 Lakh (down 3% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year. EBITDA fell 18% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹43,990 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹15,832 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.8% | ||
| Net Profit Margin | 0.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Progrezo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Progrezo Pharmaceuticals Private Limited
Progrezo Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anshul Gupta | Director | 07 Apr 2015 | 11 Years 6 Months | As last reported |
| Anjani Kumar | Director | 07 Apr 2015 | 11 Years 6 Months | As last reported |
Peer comparison
Progrezo Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medigard Pharmaceuticals Private Limited | ₹24.14 Lakh (FY 2023) | 77.0% | Thiruvananthapuram, Kerala, India | |||
| Mehar Pharmaceuticals Private Limited | ₹24.12 Lakh (FY 2024) | 46.0% | Chandigarh, India | |||
| Progrezo Pharmaceuticals Private Limitedthis company | ₹23.99 Lakh (FY 2018) | ₹15,832 | 0.7% | -3.0% | Karnal, Haryana, India | |
| Ranikem Pharmaceuticals Private Limited | ₹23.96 Lakh (FY 2025) | -15.0% | Mumbai, Maharashtra, India | |||
| Neuralink Pharmaceuticals (OPC) Private Limited | ₹23.89 Lakh (FY 2023) | 196.0% | Bhubaneswar, Odisha, India |
To see the full peer comparison of Progrezo Pharmaceuticals Private Limited, buy the company report.
Auditor
Progrezo Pharmaceuticals Private Limited is audited by VINEYGOEL&ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINEYGOEL&ASSOCIATES | FY 2017 | 012188N |
Shareholding
The shareholding of Progrezo Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Progrezo Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Progrezo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Progrezo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Progrezo Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Progrezo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Progrezo Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Anjani Kumar was appointed as Director on 07 Apr 2015.
Frequently asked questions
Progrezo Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Progrezo Pharmaceuticals was a private limited company based in Karnal, Haryana, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 07 April 2015 and is registered under CIN U74140HR2015PTC055103. The company has been struck off by the Registrar of Companies and is no longer operational.
Progrezo Pharmaceuticals had 2 directors:
- Anshul Gupta - Director
- Anjani Kumar - Director
The CIN (Corporate Identification Number) of Progrezo Pharmaceuticals is U74140HR2015PTC055103. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Progrezo Pharmaceuticals is at Plot No 147 Sector 3 Hsiidc Industrial Estate, Karnal, Haryana, India – 132001.
Progrezo Pharmaceuticals was incorporated on 07 April 2015. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Progrezo Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from FY 2016 are in the company report.
No. Progrezo Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Progrezo Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
The peers of Progrezo Pharmaceuticals by revenue are Medigard Pharmaceuticals Private Limited, Mehar Pharmaceuticals Private Limited, Ranikem Pharmaceuticals Private Limited, Neuralink Pharmaceuticals (OPC) Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anjani Kumar was appointed as Director on 07 Apr 2015. Anshul Gupta was appointed as Director on 07 Apr 2015.